CGM High but Fasting Labs Normal Explained
Your CGM is hitting 150 or 160 after a meal. Your fasting glucose came back at 92. Your A1c is 5.4. The lab report says normal. The device says something else entirely.\n\nThis is one of the most common and confusing situations we see in our Schaumburg practice. The short answer: your CGM is detecting early insulin resistance that standard fasting labs cannot catch yet. The fasting numbers look fine because your pancreas is still compensating, secreting extra insulin to keep baseline glucose in range. After a carbohydrate load, that compensation has its limits, and your blood sugar climbs higher and stays elevated longer than it should.
Why Fasting Labs Miss the Postprandial Problem
Fasting glucose and A1c are solid screening tools. They are also, by definition, pictures of a resting state. Fasting glucose measures blood sugar after 8-12 hours without food. A1c reflects a 90-day average. Both are weighted heavily toward your overnight fasting window, when insulin demand is low and the body has had hours to recover.
What neither test captures is what happens in the 1-3 hours after a meal. This is where insulin resistance first shows up. Muscle cells become sluggish at pulling glucose out of the bloodstream. The liver is slow to suppress its own glucose output. Blood sugar rises higher and stays elevated longer than it should. If the postprandial window is where your metabolism is struggling, fasting labs will look completely unremarkable. A perfectly normal A1c of 5.3 can coexist with dozens of daily excursions above 150 mg/dL, as long as fasting and overnight numbers stay low enough to pull the average down.
What Your CGM Is Actually Seeing
CGM devices (Libre, Dexcom, Stelo) measure glucose in interstitial fluid every 1-5 minutes and capture the full curve: the rise, the peak, and how fast you recover. That recovery slope carries clinical information a single fasting number cannot.
For reference, here are thresholds used in metabolic research and clinical practice:
| CGM Metric | Optimal Range | Pattern Worth Investigating |
|---|---|---|
| Postprandial peak | Below 140 mg/dL | Consistently 140-160 or above |
| Time above 140 mg/dL | Less than 5% of day | Above 10-15% of day |
| Fasting/overnight glucose | 70-100 mg/dL | Above 100 or erratic overnight swings |
| Glucose variability (SD) | Below 15 mg/dL | Above 20-25 mg/dL |
Hitting 150-160 after a bowl of pasta with glucose staying above 130 for two and a half hours is not a harmless anomaly, even if your A1c is 5.3. The CGM is showing you the extra work your pancreas is doing behind the scenes. That compensatory burden is exactly what matters for long-term metabolic health.
The Missing Test: Fasting Insulin and HOMA-IR
Most standard metabolic panels do not include fasting insulin. This omission explains most of the confusion we see.
Fasting insulin tells you how hard the pancreas is working just to keep baseline glucose in the normal range. A fasting insulin above 10-12 uIU/mL, paired with a fasting glucose that looks unremarkable, is a textbook picture of compensated insulin resistance. The compensation is working, for now.
HOMA-IR combines both values into a single number:
HOMA-IR = (fasting glucose x fasting insulin) / 405
Below 1.5 is generally considered optimal. Above 2.0 suggests meaningful insulin resistance. Above 2.5-3.0 tracks with metabolic syndrome risk. Your glucose in this formula can be perfectly normal (say, 90 mg/dL) while elevated fasting insulin pushes HOMA-IR well above 3.0.
What we typically see: a patient arrives with CGM data already in hand, alarmed by the numbers. Fasting glucose is 91. Fasting insulin is 18. HOMA-IR is 4.0. The CGM pattern makes complete sense once insulin enters the picture.
Visceral adiposity drives much of this. How accurately a DEXA scan can quantify visceral fat matters here because excess visceral fat is a primary driver of hepatic insulin resistance, long before fasting glucose begins to climb.
Common CGM Patterns and What They Signal
Dawn Phenomenon
Glucose naturally rises 15-30 mg/dL between roughly 4 a.m. and 8 a.m., driven by cortisol and growth hormone releasing stored glucose from the liver. A moderate rise is normal physiology. If your fasting glucose is 108 after a dawn rise from 83, that is a different clinical picture than a true impaired fasting glucose that starts high and stays there all morning.
Post-Meal Spikes
The critical variable is not just the peak but how long you stay elevated. A spike to 155 that returns below 100 within 90 minutes is different from one that parks above 130 for three hours. The latter points toward impaired early-phase insulin secretion or more severe peripheral resistance, and it is the pattern we pay closest attention to when reviewing CGM data.
Late-Night Eating
Eating within 2-3 hours of sleep extends postprandial elevation into the overnight window. This compresses recovery time and can raise the apparent fasting glucose that would show up on a morning lab draw, giving the misleading impression of a fasting problem when the real issue is meal timing.
Stress and Sleep
Cortisol is glucogenic. A single night of poor sleep can raise fasting glucose by 10-15 mg/dL in someone with baseline insulin resistance. This is reproducible in CGM data and worth tracking systematically, particularly before attributing an elevated morning reading to food choices.
A Decision Framework for Next Steps
If your CGM is concerning but fasting labs look normal, work through this sequence before drawing conclusions or making major changes:
- Request fasting insulin with your next fasting glucose panel. Calculate HOMA-IR. This single addition transforms a one-dimensional fasting screen into a meaningful insulin resistance assessment.
- Ask about an oral glucose tolerance test (OGTT). A 2-hour postprandial value above 140 mg/dL meets the clinical threshold for impaired glucose tolerance, even with a normal A1c.
- Adjust macronutrient timing. Front-load protein and fat at meals. Eat fiber before carbohydrates. Reduce refined starches, especially at dinner.
- Prioritize sleep. Insulin sensitivity improves measurably with consistent 7-8 hours. This is not optional for metabolic health.
- Add post-meal movement. A 10-minute walk after eating reduces postprandial spikes by activating muscle glucose uptake independent of insulin.
- Recheck in 90 days. A1c and CGM time-in-range metrics should move together if the intervention is working.
For patients in the Naperville area who arrive with CGM data already in hand, this kind of structured follow-up often reveals the missing piece of the metabolic puzzle. We take a data-driven approach that mirrors what a preventive longevity physician in the Chicago suburbs would apply: labs, imaging, wearable data, and clinical judgment working in concert.
When to Bring Medication Into the Conversation
Diet, sleep, and movement are first-line. They are also genuinely effective when implemented consistently. But there are situations where we discuss pharmacologic support.
Metformin has strong long-term data for prediabetes prevention and is FDA-approved for that indication. If HOMA-IR is persistently above 3.0, if CGM shows more than 10-15% time above 140 mg/dL despite three to six months of consistent lifestyle changes, or if there is a dense family history of type 2 diabetes, a conversation about metformin is clinically reasonable and well-supported by evidence.
GLP-1 receptor agonists are increasingly discussed for early insulin resistance, but their use in non-diabetic patients without obesity remains largely off-label and requires a careful evaluation of your full clinical picture. Never adjust any medication based on CGM readings alone. This is a decision that belongs in an in-person conversation with your physician, not in a forum thread.